rs672932

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001304990.2(SPRY3):​c.-282+73667G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.344 in 110,201 control chromosomes in the GnomAD database, including 5,745 homozygotes. There are 10,745 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 5745 hom., 10745 hem., cov: 22)

Consequence

SPRY3
NM_001304990.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0560

Publications

0 publications found
Variant links:
Genes affected
SPRY3 (HGNC:11271): (sprouty RTK signaling antagonist 3) Involved in negative regulation of MAPK cascade. Predicted to be located in membrane. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
TMLHE (HGNC:18308): (trimethyllysine hydroxylase, epsilon) This gene encodes the protein trimethyllysine dioxygenase which is the first enzyme in the carnitine biosynthesis pathway. Carnitine play an essential role in the transport of activated fatty acids across the inner mitochondrial membrane. The encoded protein converts trimethyllysine into hydroxytrimethyllysine. A pseudogene of this gene is found on chromosome X. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
TMLHE Gene-Disease associations (from GenCC):
  • epsilon-trimethyllysine hydroxylase deficiency
    Inheritance: Unknown, XL Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • autism spectrum disorder
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.575 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001304990.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPRY3
NM_001304990.2
MANE Select
c.-282+73667G>A
intron
N/ANP_001291919.1O43610
SPRY3
NM_001394353.1
c.-282+29289G>A
intron
N/ANP_001381282.1O43610
SPRY3
NM_001394354.1
c.-349-50594G>A
intron
N/ANP_001381283.1O43610

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPRY3
ENST00000695325.1
MANE Select
c.-282+73667G>A
intron
N/AENSP00000511806.1O43610
TMLHE
ENST00000675642.1
c.-152-16373C>T
intron
N/AENSP00000502604.1Q9NVH6-8
TMLHE
ENST00000902548.1
c.-2+32713C>T
intron
N/AENSP00000572607.1

Frequencies

GnomAD3 genomes
AF:
0.344
AC:
37846
AN:
110151
Hom.:
5737
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.583
Gnomad AMI
AF:
0.308
Gnomad AMR
AF:
0.332
Gnomad ASJ
AF:
0.234
Gnomad EAS
AF:
0.274
Gnomad SAS
AF:
0.259
Gnomad FIN
AF:
0.221
Gnomad MID
AF:
0.194
Gnomad NFE
AF:
0.238
Gnomad OTH
AF:
0.327
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.344
AC:
37872
AN:
110201
Hom.:
5745
Cov.:
22
AF XY:
0.330
AC XY:
10745
AN XY:
32529
show subpopulations
African (AFR)
AF:
0.583
AC:
17610
AN:
30226
American (AMR)
AF:
0.332
AC:
3429
AN:
10338
Ashkenazi Jewish (ASJ)
AF:
0.234
AC:
616
AN:
2628
East Asian (EAS)
AF:
0.273
AC:
956
AN:
3502
South Asian (SAS)
AF:
0.256
AC:
669
AN:
2617
European-Finnish (FIN)
AF:
0.221
AC:
1278
AN:
5789
Middle Eastern (MID)
AF:
0.190
AC:
40
AN:
211
European-Non Finnish (NFE)
AF:
0.238
AC:
12562
AN:
52708
Other (OTH)
AF:
0.334
AC:
504
AN:
1507
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
818
1636
2453
3271
4089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.303
Hom.:
2156
Bravo
AF:
0.364

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.61
DANN
Benign
0.41
PhyloP100
0.056

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs672932; hg19: chrX-154915975; API